Skip to contentV
Vaccinex, Inc.
V
VCNXVaccinex, Inc. Q2 2021 · 10-Q
Revenue$0.00$0.00derivedno prior Q2 2020 on file Net Income-$5.97M-$5.97MN/M vs Q2 2020 EPS Diluted-$0.21-$0.21N/M vs Q2 2020 Operating Income-$5,669,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
Operating Cash Flowderived-$6,982,000N/M ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end